Zobrazeno 1 - 10
of 74
pro vyhledávání: '"M. F. Scanlon"'
Autor:
J. Salvador, M. D. Rodríguez-Arnao, C. Diéguez, S. Foord, J. Peters, M. F. Scanlon, E. Moncada, A. Gómez-Pan, R. Hall
Publikováno v:
Revista de Medicina de la Universidad de Navarra. :11-18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33b166630fbe1f3d97e74c5a9d66457f
https://doi.org/10.15581/021.27.6067
https://doi.org/10.15581/021.27.6067
Publikováno v:
Annals of the New York Academy of Sciences. 904:576-583
Dual-energy X-ray absorptiometry was used to analyze the regional tissue distribution of bone mineral mass (BMM), fat mass (FM), and lean tissue mass (LTM) in the arms, trunk, and legs of 23 male growth hormone-deficient (GHD) males. Patients were as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17d3941e10b9b87a47b2d81007f9acc5
https://doi.org/10.1111/j.1749-6632.2000.tb06519.x
https://doi.org/10.1111/j.1749-6632.2000.tb06519.x
Publikováno v:
Journal of Neuroendocrinology. 10:377-381
We investigated the role of hypothalamic glutamate receptors in mediating the stimulatory effect of low glucose (< 5 mM) on somatostatin release. We also studied whether alteration in glutamate release might contribute to the reduced hypothalamic som
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a384719d81c71f77380f91f0b8d2d78f
https://doi.org/10.1046/j.1365-2826.1998.00218.x
https://doi.org/10.1046/j.1365-2826.1998.00218.x
Publikováno v:
Journal of postgraduate medicine. 52(3)
Rising thyroid stimulating hormone (TSH) levels in patients being treated for primary hypothyroidism usually indicate poor compliance with thyroxine therapy. In rare instances, drugs or diseases affecting absorption of thyroxine or drugs that acceler
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a322842225075e59bdefb9731119c47c
https://pubmed.ncbi.nlm.nih.gov/16855322
https://pubmed.ncbi.nlm.nih.gov/16855322
Publikováno v:
American journal of human biology : the official journal of the Human Biology Council. 16(5)
The purpose of the present study was to identify the effect of treatment with recombinant human growth hormone (rhGH) on seven somatic characteristics and eight clinical cardiovascular risk factors. Twenty-seven male and 24 female patients between th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::234c7199c04a7e42655bc14a435c4486
https://pubmed.ncbi.nlm.nih.gov/15368601
https://pubmed.ncbi.nlm.nih.gov/15368601
Publikováno v:
Journal of neuroendocrinology. 14(5)
Epidermal growth factor (EGF) causes pituitary GH3 cells to change from their normal predominantly rounded morphology to much more elongated cells with extensive filopodia, and this effect is accompanied by a parallel increase in cell volume. In view
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::636d94bbe076cad1cf6000aa747e4a7f
https://pubmed.ncbi.nlm.nih.gov/12000541
https://pubmed.ncbi.nlm.nih.gov/12000541
Publikováno v:
Clinical endocrinology. 56(4)
Untreated growth hormone deficiency (GHD) is implicated in the increased cardiovascular risk associated with adult hypopituitarism. Oxidative stress, predisposing to lipid peroxidation, may be an important mediator of endothelial dysfunction, a pro-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::185d63ef4e33411882f89453417bc26f
https://pubmed.ncbi.nlm.nih.gov/11966737
https://pubmed.ncbi.nlm.nih.gov/11966737
Autor:
Jamie C, Smith, L M, Evans, I, Wilkinson, J, Goodfellow, J R, Cockcroft, M F, Scanlon, J S, Davies
Publikováno v:
Clinical endocrinology. 56(4)
Hypopituitary adults with growth hormone deficiency (GHD) have an increased cardiovascular mortality, although the mechanisms remain unclear. Endothelial dysfunction, characterized by reduced nitric oxide (NO) bioavailability, is a key early event in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9a81ffbba90550141af0a5726fe6deb4
https://pubmed.ncbi.nlm.nih.gov/11966742
https://pubmed.ncbi.nlm.nih.gov/11966742
Publikováno v:
Clinical endocrinology. 56(4)
Transsphenoidal selective adenomectomy (TSA) is widely accepted as the treatment of choice for Cushing's disease but not all patients are cured by this procedure. The success of surgery depends on the skill and experience of the surgeon but the crite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b8a3c47aa564b480ef11712e4b42f76b
https://pubmed.ncbi.nlm.nih.gov/11966748
https://pubmed.ncbi.nlm.nih.gov/11966748
Publikováno v:
Clinical endocrinology. 53(5)
Cabergoline therapy normalizes prolactin levels and reduces the size of macroprolactinomas. However there are no data indicating whether cabergoline can normalize growth hormone secretion in patients who were growth hormone deficient at the time of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8f4fcb258febaa8d2b2c67b0ba634c4e
https://pubmed.ncbi.nlm.nih.gov/11106920
https://pubmed.ncbi.nlm.nih.gov/11106920